October 20, 2026

LifeStance Health Group, Inc. (LFST) Stock Analysis: Exploring a 22% Upside Potential in the Booming Mental Health Sector

LifeStance Health Group, Inc. (NASDAQ: LFST), a leading player in the medical care facilities industry, has captured investor interest with its focus on outpatient mental health..

Disc Medicine, Inc. (IRON) Stock Analysis: Impressive 47.81% Potential Upside Beckons Investors

Disc Medicine, Inc. (NASDAQ: IRON), a biotechnology company specializing in treatments for serious hematologic diseases, is capturing investor interest with its substantial growth potential. Operating in..

Envista Holdings Corporation (NVST): Investor Outlook Reveals 26.9% Upside Potential

Envista Holdings Corporation (NYSE: NVST), a key player in the healthcare sector specialized in medical instruments and supplies, presents a promising opportunity for investors seeking exposure..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Explosive Revenue Growth and Strong Buy Ratings Drive a Promising Investor Outlook

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) stands out in the biotech sphere with its strong focus on addressing unmet medical needs in autoimmune diseases. With a market..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: Strong Revenue Growth and Attractive Upside Potential

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH), a prominent player in the U.S. healthcare sector, is capturing investor attention with its robust revenue growth and significant upside..

Evolent Health, Inc (EVH): Analyst Ratings Suggest a 28% Upside Potential

Evolent Health, Inc (EVH), a key player in the health information services industry, has captured investor attention with a promising potential upside of 28.35%. Despite its..

Supernus Pharmaceuticals (SUPN) Stock Analysis: Is a 51.86% Upside Within Reach?

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) is making waves in the healthcare sector, specifically within the drug manufacturing industry focused on specialty and generic medications. With a..

Celldex Therapeutics, Inc. (CLDX) Investor Outlook: Analyzing the 112.58% Potential Upside

Celldex Therapeutics, Inc. (NASDAQ: CLDX), a prominent player in the biotechnology sector, is capturing significant attention within the investment community, thanks to its substantial potential upside..

LivaNova PLC (LIVN) Stock Analysis: Exploring a 15.88% Upside Potential in the Healthcare Sector

LivaNova PLC (NASDAQ: LIVN), a prominent player in the medical devices industry, presents an intriguing opportunity for investors seeking exposure to the healthcare sector. With a..

GeneDx Holdings Corp. (WGS) Stock Analysis: Discovering a 41% Upside Potential in Genomics

GeneDx Holdings Corp. (NASDAQ: WGS), a prominent player in the burgeoning genomics sector, has drawn considerable attention from investors seeking opportunities in the healthcare industry. With..

Liquidia Corporation (LQDA) Stock Analysis: Exploring a 59% Potential Upside in the Biopharma Sector

Liquidia Corporation (NASDAQ: LQDA) is making waves in the biopharmaceutical industry with its innovative approach to treating rare cardiopulmonary diseases. With a market capitalization of $3.05..

CG Oncology, Inc. (CGON) Stock Analysis: Exploring a Potential 51.90% Upside in the Biotechnology Sector

Investors with a keen eye on the biotechnology sector may find CG Oncology, Inc. (NASDAQ: CGON) an intriguing prospect, especially given its potential upside of 51.90%...

Pulse Biosciences, Inc (PLSE): Investor Outlook Reveals a 31% Potential Upside

Pulse Biosciences, Inc. (NASDAQ: PLSE) is capturing the attention of investors with its innovative approach to bioelectric medicine. As a key player in the Medical Instruments..

Ardent Health, Inc. (ARDT) Stock Analysis: Unpacking Growth Potential and Analyst Ratings

Ardent Health, Inc. (ARDT), a key player in the United States’ healthcare sector, operates an extensive network of hospitals and clinics, providing a wide array of..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: A 58% Upside Potential Amid Strong Revenue Growth

For investors seeking opportunities in the healthcare sector, Alignment Healthcare, Inc. (ALHC) presents a compelling case with its impressive revenue growth and significant upside potential. The..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Impressive Return on Equity and a Promising Upside

For investors seeking opportunities in the healthcare sector, Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) presents a compelling case. With its significant upside potential and a remarkable return..

Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Exploring a 102.68% Potential Upside in Biotechnology

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX), a clinical-stage biotechnology firm, is at the forefront of revolutionizing drug discovery through its integration of technological innovations across biology, chemistry,..

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: Exploring a 156.84% Potential Upside in the Biotech Sector

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is emerging as a compelling opportunity in the healthcare sector, particularly for investors with an appetite for biotech stocks. With a..

10x Genomics, Inc. (TXG) Stock Analysis: Navigating a Complex Valuation with Promising Upside

10x Genomics, Inc. (NASDAQ: TXG), a prominent player in the healthcare sector, specializes in medical devices that enhance the analysis of biological systems. With a market..

ImmunityBio, Inc. (IBRX) Stock Analysis: A 69% Potential Upside in the Biotech Arena

ImmunityBio, Inc. (NASDAQ: IBRX), a San Diego-based biotechnology firm, is making waves in the healthcare sector with its pioneering approach to immunotherapy. As the company focuses..

Search

Funds

October 20, 2026

Search

Funds

October 20, 2026

FTSE 100

Funds